ORTEXORTEX News

Articles

Trader Note9345 total

JSW logo
Trader NoteJSW

JSW Into Earnings Eve: Short Score at 85.4, Bears Still Dug In

JSW — Jastrzębska Spółka Węglowa — arrives at earnings eve with its ORTEX short score at a fresh high, borrow costs at their steepest level in weeks, and the stock up 8% on the week — a setup where the stock and the…

1 min read
SOUN logo
Trader NoteSOUN

SOUN: The Short Book Keeps Shrinking, But Borrow Stays Sealed

SoundHound AI ends the week with a cleaner short-interest picture than it has seen in months — yet the structural conditions underneath remain almost entirely unchanged. Short interest has continued its post-earnings…

1 min read
AAPL logo
Trader NoteAAPL

Apple's Post-Earnings Drift Continues as Borrow Costs Ease

AAPL has extended its post-earnings slide into a third week, now down roughly 2.5% on the week and more than 3% over the past month, as the market continues to digest a fractured Street view and the lingering shadow of…

1 min read
ALKS logo
Trader NoteALKS

ALKS Shorts Rebuild After Earnings Selloff

Alkermes enters the week with a notable tension: short sellers are rebuilding positions aggressively into a stock that has already lost nearly 5% over the past month, while options traders are rotating away from the…

1 min read
WEN logo
Trader NoteWEN

WEN Squeezes Higher but Bears Haven't Left

WEN has rallied 12% on the week to $8.64 — its best weekly performance since early this year — yet short interest remains near 31% of the free float and options traders have turned notably more defensive, creating the…

1 min read
RKLB logo
Trader NoteRKLB

RKLB Creeps Back Toward Beck's Selling Range

Rocket Lab Corporation is trading at $80.25 — flat on the week, still below the ceiling its own CEO set, and with short sellers now holding a slightly rebuilt position after covering into earnings. The most important…

1 min read
IOVA logo
Trader NoteIOVA

IOVA: Short Book Holds as Bears Lose Another Week

Iovance Biotherapeutics is now up 78% in a single month and the short book, despite a week of further trimming, remains one of the heaviest in biotech — a standoff that grows more expensive for bears with each passing…

1 min read
AMGN logo
Trader NoteAMGN

Amgen Rallies 18% in a Month — Shorts Stay Wary

AMGN heads into the back half of August riding an 18% one-month surge, yet the positioning data tells a more cautious story beneath the surface. The most striking feature of the current setup is the distance the stock…

1 min read
OBX logo
Trader NoteOBX

OBX Gives Back a Third of Its Gains in Five Days

OBX has gone from a year-to-date standout to the week's most dramatic reversal in biotech — down 35% in five sessions after a 2026 run that had briefly taken it up more than 340%. The borrow market tells a story of…

1 min read
ENRD logo
Trader NoteENRD

ENRD Borrow Tightens Further as Earnings Land Monday

ENRD heads into its Monday earnings print with the lending market at maximum stress — availability has now hit zero, cost to borrow has climbed to a new recent high, and short interest has almost tripled in share terms…

1 min read
PS logo
Trader NotePS

PS Earnings Beat Shifts the Story, But Shorts Hold Their Ground

Pershing Square Inc. posted a 5.2% gain on August 13 following its earnings release — and the week's most interesting question is what has changed in positioning since, because the answer is: less than the rally might…

1 min read